Adopted MeasuresDeveloping MeasuresStanding WorkgroupsResourcesBibliography
Stakeholder Education Workgroup

 

Chair: Constance M. Horgan, Sc.D. Dr. Horgan is a Professor at the Heller School for Social Policy and Management, Brandeis University and the founding Director of its Institute for Behavioral Health, which focuses on the intersection of health, behavior and systems of care. Dr. Horgan has focused her research on studying how behavioral health services are financed, organized, and delivered in the public and private sectors and what approaches can be used to improve the quality and effectiveness of the delivery system. She has over twenty-five years of experience in health policy analysis and services research in both academic and government settings. She has been involved with numerous national studies involving health surveys of both individuals and organizations, as well as extensive use of administrative data. She currently directs the Brandeis/Harvard Center on Managed Care funded by the National Institute on Drug Abuse (NIDA) and leads several other studies related to the delivery of alcohol, drug and mental health services. She also directs a National Institute for Alcohol Abuse and Alcoholism (NIAAA) doctoral training program in health services research and teaches courses in behavioral health and substance abuse policy. She has led studies for the Substance Abuse and Mental Health Services Administration (SAMHSA), Agency for Healthcare Research and Quality (AHRQ), National Institute of Mental Health (NIMH), NIDA, NIAAA, and foundations, including Robert Wood Johnson. Dr. Horgan has written numerous articles and served on expert panels and advisory committees for federal agencies, professional associations, and academic and community task forces.
Back to top


Joann Albright, Ph.D. is Senior Vice President of Quality, Outcomes and Research at Magellan Health Services, directing its the quality, outcomes and research programs.  Magellan Health Services is a specialty services managed care company providing behavioral health management, radiology management and specialty pharmacy management services.  Dr. Albright leads a national team in policy and standard development, quality operations, survey and evaluation procedures, patient safety enhancement, and in the development and monitoring of performance and outcomes measures. Dr. Albright coordinates research initiatives with academic institutions designed to translate research into practice.   Dr. Albright received her Ph.D. in psychology from the University of Denver and is a licensed psychologist.  She has authored or served as project director for nine national grants, conducted research on brief therapy and has clinical experience in inpatient, outpatient and university treatment settings.   Dr. Albright has twenty-five years of clinical experience, ten of which have been in managed care directing clinical, quality and outcomes programs.
Back to top


John Bartlett M.D., MPH. is a Yale and UCLA-trained psychiatrist and manager and a widely respected thinker and visionary on the management and improvement of behavioral healthcare, particularly through the design and development of effective organizational capabilities and infrastructure. He is currently a principal with the Avisa Group, a consulting firm with expertise in policy formulation and program development in behavioral healthcare. In addition to his work with the Avisa Group, Dr. Bartlett currently serves as the executive director of the Forum on Performance Measures in Behavioral Healthcare, a national public policy group devoted to the improvement of treatment and service delivery in behavioral healthcare and prevention through the development and implementation of effective and efficient approaches to accountability and improvement. He also serves as a member of the Policy Committee of the Washington Circle Group, which seeks to improve substance abuse treatment and prevention through the development and dissemination of addiction-specific standards and measures. Dr. Bartlett has extensive experience in both the public and private sectors. Following the completion of his training at UCLA, where he was a Robert Wood Johnson Clinical Scholar and received a MPH in Health Services Management from the UCLA School of Public Health, Dr. Bartlett worked as the Assistant Chief of Staff at the Wadsworth VA Medical Center. In the private sector he has held a number of senior level positions, including that of executive vice president for clinical strategies at Magellan Health Services, currently the nation’s largest managed behavioral healthcare organization; corporate medical director of MCC Behavioral Care, a CIGNA subsidiary; and regional medical director for CIGNA Private Practice Plan, an IPA-type HMO in southern California. In addition, Dr. Bartlett is active at the national level in a variety of roles. These include his past chairmanship of the Quality Improvement and Clinical Services Committee of the American Managed Behavioral Healthcare Association, where for three years he led the development of PERMS, the association's set of performance measures for managed behavioral healthcare programs. Dr. Bartlett also serves as a member of the Behavioral Measures Advisory Panel of the National Committee for Quality Assurance and as a member of the Technical Advisory Panel for the National Quality Forum’s initiative on evidence-based practices for substance use disorder treatment.
Back to top


Rhonda J. Robinson Beale, M.D. is Chief Medical Officer of United Behavioral Health (UBH), where she is responsible for facilitating the clinical direction, quality of care and clinical policy of the organization. Prior to coming to UBH she was the Chief Medical Officer for PacifiCare Behavioral Health prior to its acquisition by UBH. Dr. Robinson Beale has been very active with national organizations and initiatives involving quality. She is currently a member of the Institute of Medicine Health Services Board and is serving on an IOM study examining psychosocial services need for cancer patients due to be published later this year. She has also served on the IOM Neuroscience and Behavioral Health Board. Other important work with the IOM included work on the IOM committee which produced the national studies, “To Err is Human” and “Crossing the Quality Chasm.”  She was a co-author of the IOM’s “Managing Managed Care Quality Improvement in Behavioral Health” study in 1997. Dr Robinson Beale is currently co-chairing a National Quality Forum Steering Committee working on “Evidence-Based Practices to Treat Substance Use Conditions’. She was also on the Technical Advisory Committee to review behavioral health Ambulatory standards. She has also been a member of NCQA’s Review Oversight Committee for six years and was a member of the Behavioral Medicine Subcommittee that wrote and refined the behavioral medicine standards for health care businesses.  She is currently serving on the IOM Health Services Board. During the last 10 years, she has presented extensively on a variety of quality and care management themes.  Before joining UBH, Dr. Robinson Beale was with CIGNA Behavioral Health in 2002 as the Chief Medical Officer. She was also at Blue Cross Blue Shield of Michigan as its National Medical Director and Medical Director over disease, and case management and their nurse call in line for their indemnity product.  Prior to that, she was Health Alliance Plan’s (HAP) Senior Medical Director - Behavioral Medicine where she helped design their behavioral health managed care system. Dr. Robinson Beale has over 30 years of private practice experience in general psychiatry and, substance abuse particularly drug addicted mothers. She completed her M.D. training at Wayne State University School of Medicine in 1975 and interned at Detroit’s Hutzel Hospital, completing her residency at the Detroit Psychiatric Institute.
Back to top


Mady Chalk, Ph.D. is the Director of the Center for Performance-Based Policy at the Treatment Research Institute (TRI) where she directs collaborations between and among researchers, state and local policy makers, purchasers, elected officials, and treatment providers to develop policy-based strategies for improving delivery of addiction treatment.  Prior to joining TRI, for many years Dr. Chalk was Director of the Division of Services Improvement in the Center for Substance Abuse Treatment (CSAT)/Substance Abuse and Mental Health Services Administration (SAMHSA). Dr. Chalk provided federal leadership for the discretionary grant program at CSAT and for its quality improvement programs, including the Washington Circle Group.  On behalf of CSAT she participated in NiaTx, implementation of the Center’s science-to-service/best practices agenda, its organization and financing studies, and workforce development activities. Dr. Chalk provided leadership for a number of innovative new State-wide programs related to increasing access to alcohol and drug treatment, including a program in general medical settings that provides screening, brief interventions, and referrals to treatment.  Before joining the federal government, Dr. Chalk was Senior Program Officer at the National Academy of Sciences, Institute of Medicine. She received her Ph.D. in Health and Social Policy from the Heller School at Brandeis University.  For 15 years before coming to the Washington area, Dr. Chalk was a faculty member in the Yale University School of Medicine, Department of Psychiatry, and the Director of the Outpatient /Community Services Division of Yale Psychiatric Institute.
Back to top  


Michael T. Flaherty, Ph.D. is a Clinical Psychologist and the Executive Director of the Institute for Research, Education and Training in Addictions (IRETA), as well as the Principal Investigator, Northeast Addiction Technology Transfer Center (NeATTC).IRETA is dedicated to aligning research and practice through education and policy development.  IRETA’s mission is to be a repository of information related to addictions, research policy, prevention, intervention and treatment and to develop effective mechanisms to transfer that knowledge to the substance abuse field and policy makers.  Dr. Flaherty has over 30 years experience in the addictions, 25 while serving as Executive Director of the St. Francis Institute for Psychiatry an   Addiction Services in Pittsburgh. He has written or administered 18 Federal grants and published work in areas such as: (1) Intergenerational Substance Abuse Vulnerability; (2) Pregnancy and Addiction; (3) Alternatives to Incarceration; (4) Technology Transfer; (5) Aligning Policy – Service – Science; and (6) payment methodologies to support Qualitative Performance and Outcomes. Dr. Flaherty received B.A. degrees in both Psychology and Philosophy from Pennsylvania State University, and earned both an M.A. and Ph.D. in Clinical Psychology from Duquesne University.  He also did post graduate work at the U.S. Naval War College and at the National Defense University.  Dr. Flaherty is a retired Captain in the United States Naval Reserve.
Back to top


Deborah Garnick, Ph.D. is a Professor in the Institute for Behavioral Health at The Heller School for Social Policy and Management at Brandeis University and Associate Dean, Academic Personnel.  She received her doctorate in health services research from the School of Hygiene and Public Health at Johns Hopkins University (now the Bloomberg School of Public Health).  During the first ten years of her career, when Dr. Garnick’s research was focused on the quality of hospital services, she explored the issues of hospital market areas, patients’ decisions to select hospitals based on quality, and hospital outcomes.  With colleagues at the University of California, she focused on the relationship of hospital volume and patient outcomes, then a newly emerging area of research. Currently, Dr. Garnick leads the Brandeis team in a collaboration with RTI focused on technical development of the National Outcome Measures (NOMS) for behavioral health in a project funded by the Substance Abuse and Mental Health Administration (SAMHSA). She has led NIH-funded studies focused on exploring the association between substance performance measures and outcomes.  She serves as is the Co-Principal Investigator on studies that involve tracking of drug and alcohol abuse services and mental health services provided by the managed behavioral health care industry.  In addition, she is a member of the Washington Circle Policy Group and leads their workgroup on public sector performance measures for substance abuse.  Dr. Garnick often serves as an expert consultant, most recently as a member of the National Quality Forum’s Substance Use Disorders and Evidence Based-Practices Technical Advisory Panel. Dr. Garnick has published widely the topics of injuries among Medicare and Medicaid beneficiaries, state-level health insurance reform legislation, quality of hospital and ambulatory care, methods of using data collected for administrative purposes for health services research, and performance measures for substance abuse.
Back to top


Pamela Greenberg, MPP is the President and CEO of the Association for Behavioral Health and Wellness (ABHW – formerly the American Managed Behavioral Healthcare Association).  ABHW is an association of the nation’s leading behavioral health and wellness companies.  These companies provide an array of services related to mental health, substance use, employee assistance, disease management, and other health and wellness programs to over 110 million people in both the public and private sectors.Greenberg serves on the Editorial Board of the Bureau of National Affairs Health Plan and Provider Report and BEHAVIORAL HEALTHCARE.  She also is the Chair of the Coalition for Fairness in Mental Illness Coverage and a member of:  the Mental Health Liaison Group Steering Committee, the Treatment/Recovery Information and Advocacy Database (TRIAD) Advisory Group, the Client Patient Sample Survey Technical Work Group, the DS 2000+ Oversight Committee, the Washington Circle Group Policy Committee and the National Advisory Board for the UPENN Rehabilitation Research and Training Center on Community Integration of People with Psychiatric Disabilities.  She was a member of the National Committee on Employer-Sponsored Behavioral Healthcare Services, the Adult Mental Health Workgroup within the Forum for Performance Measures for Mental Health and Substance Abuse Services, the Mental Health Statistics Improvement Program (MHSIP) Consumer Report Card Workgroup, the Experience of Care and Health Outcomes (ECHOTM) Survey Development Team, the Stakeholders Advisory Council for the Substance Abuse and Mental Health Services Administration (SAMHSA) Managed Care Tracking System on Behavioral Health, and the Technical Advisory Panel for the Evaluation of the Effects of the Vermont Parity Act.  Prior to joining ABHW Greenberg was the Deputy Director of Federal Affairs for America’s Health Insurance Plans (AHIP) and, earlier, a Legislative Assistant at Capitol Associates, a healthcare consulting firm in Washington, D.C.  Greenberg serves on several Boards and has a B.A. from Mount Holyoke College and a Masters in Public Policy from Georgetown University.
Back to top


David H. Gustafson, Ph.D. is Director of University of Wisconsin-Madison’s (UCW) Center of Excellence in Cancer Communications Research, funded by the National Cancer Institute, and Director of the Network for the Improvement of Addiction Treatment, jointly funded by the Robert Wood Johnson Foundation and the Center for Substance Abuse Treatment. He is a Research Professor of Industrial and Systems Engineering at UCW, where he is the Director of the Center for Health Enhancement Systems Studies. His research interests in decision, change, and information theory come together in the design and evaluation of computer-based health communication systems to help people cope with serious illness. Dr. Gustafson’s research focuses on the use of systems engineering methods and models in individual and organizational change applied to health and healthcare. His research on individual change centers on developing and evaluating eHealth systems using as the test vehicle CHESS (the Comprehensive Health Enhancement Support System), a computer system to help people facing serious health problems with a particular focus on cancer and risk taking behaviors. His randomized control trials and field tests of CHESS help understand acceptance, use, and impact of eHealth on quality of life, behavior change, and health services utilization. His research on organizational change centers on models to understand and influence change and sustainability of change. The addiction treatment field is his primary test bed for these organizational change initiatives. Dr. Gustafson is a Fellow of the Association for Health Services Research and of the American Medical Informatics Association. He is a Fellow and past Vice–Chair of the Board of the Institute for Healthcare Improvement. He also chaired the Federal Science Panel on Interactive Communications in Health and chairs the board of the eHealth Institute. He is a member of the Institute of Medicine Committee on Redesigning Health Insurance Benefits, Payments and Performance Improvement Programs. He has received two awards from the University of Wisconsin for his humanitarian work.
Back to top


Frank McCorry, Ph.D. is the Director of the New York City Office of the Commissioner for the New York State Office of Alcoholism and Substance Abuse Services. He is responsible for clinical policy and practice improvement issues, particularly in the areas of public health, co-occurring mental health and addictive disorders and managed care. He represents OASAS on a joint initiative with the Office of Mental Health on co-occurring disorders, which is based on the “New York Model,” a conceptual paradigm for the treatment of persons with co-occurring disorders. Dr. McCorry also oversees the development of new initiatives that respond to emerging issues like improving patient outcomes through the adoption of evidence-based interventions. He is the Principal Investigator on the National Institute on Drug Abuse State Infrastructure Grant to enhance the state’s capacity to foster the adoption of evidence-based practices, and a Robert Wood Johnson Foundation grant to improve access and retention through the use process improvement approaches. Dr. McCorry is Chairperson of the Washington Circle Group, a SAMHSA-sponsored initiative to develop substance abuse performance measures for use in managed care and public sector settings. He is co-Chair of the National Quality Forum’s Evidence-based Practices to Treat Substance Use Disorders Steering Committee. He is a member of SAMHSA’s Center for Substance Abuse Treatment’s National Advisory Council. He also serves on the Editorial Board of the Journal of Substance Treatment and the External Advisory Board of the Brandeis/Harvard Center on Managed Care. Dr. McCorry has worked in the field of substance abuse prevention and treatment for over 30 years. He received his doctorate in Counseling and Human Services from St. John’s University in 1982.


Carol McDaid serves as Principal at Capitol Decisions, Inc. (CDI), a firm she founded in May 2000 as one of the only public affairs groups in the nation’s capital with a specific focus on influencing federal alcohol and other drug (AOD) policy.  She brings to the firm nearly twenty-five years of federal legislative experience in Washington, D.C., representing business and nonprofit interests in health, employee benefit, telecommunications and related tax areas.  For over a decade, Ms. McDaid has worked with leading non-profit drug and alcohol treatment centers, pharmaceutical manufacturers, and other AOD prevention and consumer organizations to refine public policy addressing alcohol and other drug addiction.  She helps clients overcome the unique political challenges posed by the stigma associated with alcohol and drug addiction.  To break down these barriers, McDaid assists AOD clients in developing legislative and regulatory campaigns that overcome stigma by blending traditional lobbying techniques with public affairs strategies that highlight the societal benefits of recovery by using provocative personal stories of the transformational power of recovery to leverage the impact or influence an AOD client has over a regulatory, legislative, or industry issue.  These strategies combine traditional health care advocacy tactics with social marketing, third party constituency building, national media relations, Internet-based grassroots communications and identification and acquisition of federal funding in both the public and private sectors.  Ms. McDaid serves on the Betty Ford Institute Executive Council, the Caron Treatment Centers National Leadership Council and the Board of Directors for Faces and Voices of Recovery.  A North Carolina native, McDaid graduated from Emory University in Atlanta, Georgia, where she majored in political science.  The focus of her graduate work was in legislative affairs at George Washington University in Washington, D.C.
Back to top